The Medicines Company (NASDAQ:MDCO) on 2016-07-27 announced an EPS of $-0.84. Estimates for the company’s EPS stand at $-1.2. A week ago the earnings estimates stood at $-1.2 changing by 0%, while a month ago they were $-1.2.
The company had received an EPS estimate of $-1.2 60 days ago while 90 days ago the estimates were at $-1.2.
In the last 7 days the company has seen 2 upward revisions in its EPS estimates while the number of downward revisions was EPS_CNT_EST_REV_DOWN_LAST_7D:1835}}. Similarly, its EPS estimates were increased 2, 2, 2 and 2 times in the last 30, 60, 90 and 120 days respectively.
In the last 120, 90, 60 and 30 days periods the EP estimates were downgraded 2, 2, 2, 2 times.
In the previous 18 days the estimates saw upward revision 2 times and downward revision 2 times.
From a total of 2 estimates, the company’s mean EPS estimate for the period ended 2 stood at $-1.2. As such the difference amount from the actual EPS was $0.36, which comes to 30%. Right before the announcement of the actual EPS, the estimates ha d a standard deviation of 0.27.
Coming to sales figures, The Medicines Company (NASDAQ:MDCO) is estimated to register annual sales of $30.4. The figure is the arithmetic mean of all estimates by 2 analysts while the median comes to $30.4 for the fiscal year 2016.
The highest estimate stands at $31.3 while lowest is $29.5. The annual sales estimate have a standard deviation of 1.272%.
In the last week 2 analysts increased their sales estimates while 2 decreased their estimates. The mean estimate changed by 0% from last week.
Over the last month, 2 analysts revised their estimates upwards while 2 analysts revised their estimates downwards. The mean estimate saw a change of -20.73% from a month ago.
Over the last 3 month period, 2 analysts revised their sales estimates for The Medicines Company (NASDAQ:MDCO) upwards while 2 analysts downgraded their estimates. The mean estimate from 3 months ago underwent a change of -29.137%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...